MAUDE Adverse Event Report: MEDTRONIC IRELAND RESOLUTE ONYX RX; CORONARY DRUG-ELUTING STENT

Model Number RONYX22530UX

Device Problems Migration or Expulsion of Device (1395); Device Dislodged or Dislocated (2923)

Patient Problem Unspecified Tissue Injury (4559)

Event Date 05/26/2021

Event Type  Injury  

Manufacturer Narrative

If information is provided in the future, a supplemental report will be issued.

Event Description

One 2.25x30mm resolute onyx coronary drug eluting stent was attempted to be used to treat a moderately tortuous, severely calcified lesion with 80% stenosis in the mid right coronary artery (rca).It was stated that there was mild restenosis of the mid rca stent.The device was inspected prior to use with no issues noted.Negative prep was performed with no issues noted.A cougar guide wire was used.A 2.5x15mm euphora balloon was used to pre-dilate the mid rca, distal plv and the ostium.The device did not pass through a previously deployed stent.Resistance was not encountered when advancing the device and excessive force was not used.A 3.5x22mmresolute onyx stent was successfully deployed at the ostium.A 2.5x20mm euphora balloon was used to further dilate the distal plv.The 2.25x30mm resolute onyx was loaded into the guide but the guide lost position as the stent was coming out.The guide was re-engaged in the ostium and it was difficult to advance the stent beyond the restenosed stent in the mid rca.The stent was pulled back but it dislodged.A balloon was unable to be advanced distally to inflate and pull back the stent.It was decided to crush the stent against the vessel wall with a 2.5x30mm euphora balloon and a 3.5x20mm nc euphora balloon.It was then noticed that the stent was not crushed against the vessel wall, it had migrated a few mm to the mid rca where the previous stent was.A 3.0x34mm resolute onyx wasthen deployed to crush the stent.It was stated that pci of the distal plv was then completed with a 2.5x20mm euphora balloon and a 2.25x30mm resolute onyx stent.No further patient injury reported.

Manufacturer Narrative

Additional information: annex d, annex g codes added correction: implant date added medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.

• Brand Name: RESOLUTE ONYX RX
• Type of Device: CORONARY DRUG-ELUTING STENT
• Manufacturer (Section D): MEDTRONIC IRELAND; parkmore business park west; galway ; EI
• MDR Report Key: 11957425
• MDR Text Key: 254854089
• Report Number: 9612164-2021-02213
• Device Sequence Number: 1
• Product Code: NIQ
• UDI-Device Identifier: 00643169556751
• UDI-Public: 00643169556751
• Combination Product (y/n): N
• PMA/PMN Number: P160043
• Number of Events Reported: 1
• Summary Report (Y/N): N
• Report Source: Manufacturer
• Source Type: company representative,health
• Type of Report: Initial,Followup
• Report Date: 07/06/2021

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Date FDA Received: 06/08/2021
• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: Yes
• Device Operator: Health Professional
• Device Expiration Date: 03/01/2022
• Device Model Number: RONYX22530UX
• Device Catalogue Number: RONYX22530UX
• Device Lot Number: 0010159147
• Was Device Available for Evaluation?: No
• Date Manufacturer Received: 06/30/2021
• Is This a Reprocessed and Reused Single-Use Device?: No
• Patient Sequence Number: 1
• Patient Outcome(s): Required Intervention
• Patient Age: 88 YR